These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. Ogura T, Yamao K, Sawaki A, Mizuno N, Hara K, Hijioka S, Niwa Y, Tajika M, Kondo S, Shimizu Y, Bhatia V, Higuchi K, Hosoda W, Yatabe Y. Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089 [Abstract] [Full Text] [Related]
3. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses. Reicher S, Boyar FZ, Albitar M, Sulcova V, Agersborg S, Nga V, Zhou Y, Li G, Venegas R, French SW, Chung DS, Stabile BE, Eysselein VE, Anguiano A. Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950 [Abstract] [Full Text] [Related]
5. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer. Bournet B, Selves J, Grand D, Danjoux M, Hanoun N, Cordelier P, Buscail L. J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941 [Abstract] [Full Text] [Related]
6. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma. Sekita-Hatakeyama Y, Nishikawa T, Takeuchi M, Morita K, Takeda M, Hatakeyama K, Nakai T, Uchiyama T, Itami H, Fujii T, Mitoro A, Sho M, Ohbayashi C. PLoS One; 2018 Jan; 13(3):e0193692. PubMed ID: 29494669 [Abstract] [Full Text] [Related]
7. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy. Trisolini E, Armellini E, Paganotti A, Veggiani C, Bozzola C, Frattini M, Pizio C, Mancuso G, Andorno S, Boldorini R. Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086 [Abstract] [Full Text] [Related]
8. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Bournet B, Souque A, Senesse P, Assenat E, Barthet M, Lesavre N, Aubert A, O'Toole D, Hammel P, Levy P, Ruszniewski P, Bouisson M, Escourrou J, Cordelier P, Buscail L. Endoscopy; 2009 Jun; 41(6):552-7. PubMed ID: 19533561 [Abstract] [Full Text] [Related]
11. Predictors of Malignancies in Patients with Inconclusive or Negative Results of Endoscopic Ultrasound-guided Fine-needle Aspiration for Solid Pancreatic Masses. Jeong H, Park CS, Kim KB, Han JH, Yoon SM, Chae HB, Youn SJ, Park SM. Korean J Gastroenterol; 2018 Mar 25; 71(3):153-161. PubMed ID: 29566476 [Abstract] [Full Text] [Related]
12. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma. Park JK, Lee YJ, Lee JK, Lee KT, Choi YL, Lee KH. Oncotarget; 2017 Jan 10; 8(2):3519-3527. PubMed ID: 27974679 [Abstract] [Full Text] [Related]
14. [KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass]. Bunganič B, Hálková T, Benešová L, Belšánová B, Laclav M, Hrůzová M, Traboulsi E, Frič P, Suchánek Š, Minárik M, Zavoral M. Cas Lek Cesk; 2016 Jan 10; 155(1):48-51. PubMed ID: 26898792 [Abstract] [Full Text] [Related]
15. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis. Wang X, Gao J, Ren Y, Gu J, Du Y, Chen J, Jin Z, Zhan X, Li Z, Huang H, Lv S, Gong Y. Am J Gastroenterol; 2011 Dec 10; 106(12):2104-11. PubMed ID: 21876563 [Abstract] [Full Text] [Related]